Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank100
3Y CAGR+147.4%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+147.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
15.2x
Strong expansion
Streak
5 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.13+22.6%
20240.10+68.9%
20230.06+632.0%
20220.01+45.7%
20210.01-
20200.00-100.0%
20190.01-
20180.00-